Expression of a Recombinant High Affinity IgG Fc Receptor by Engineered NK Cells as a Docking Platform for Therapeutic mAbs to Target Cancer Cells
通过工程化 NK 细胞表达重组高亲和力 IgG Fc 受体作为治疗性 mAb 靶向癌细胞的对接平台
期刊:Frontiers in Immunology
影响因子:5.7
doi:10.3389/fimmu.2018.02873
Kristin M Snyder, Robert Hullsiek, Hemant K Mishra, Daniel C Mendez, Yunfang Li, Allison Rogich, Dan S Kaufman, Jianming Wu, Bruce Walcheck
